DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Olanzapine (Excl. Dafo. for the Production of a Depot - Isu, Atc N05ah03 (Obo) F. 01.08.24 - 31.07.26. The project location is Germany and the tender is closing on 05 Jun 2026. The tender notice number is -, while the TOT Ref Number is 102813917.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Olanzapine (Excl. Dafo. for the Production of a Depot - Isu, Atc N05ah03 (Obo) F. 01.08.24 - 31.07.26